These findings corroborate emerging evidence implicating NUCB2 in proliferative mechanisms across various cancer types, including nasopharyngeal carcinoma, bladder cancer, hepatocellular carcinoma, colorectal cancer and thyroid cancer [24, 25, 26, 27, 28]. The gene discussed is NUCB2; the disease is thyroid gland carcinoma.